You searched for "EURETINA"
25th EURETINA Congress
4 September 2025
-7 September 2025
In conversation with Pearse Keane (2018)
1 March 2019
|
Ophthalmology, EYE - Vitreo-Retinal
AI was a hot topic at the 18th Congress of the European Society of Retina Specialists (EURETINA), following the publication of important findings in relation to using this technology in diagnosing retinal disease. We were delighted to catch Pearse Keane,...
Management of diabetic macular oedema (DMO)
1 February 2018
| Kurt Spiteri Cornish
|
Retina / Uvea / Vitreous
|
Anti-VEGF therapy, Diabetic macular edema, Steroids
The authors present guidelines on current diagnostic and therapeutic procedures in the management of DMO. Fluorescein angiography (FA) and optical coherence tomography (OCT) are recommended before starting treatment to help diagnose and stage DMO, and can be repeated if there...
Management of DMO and PDR in 2019
An evidence-based approach to the management of diabetic macular oedema (DMO) and proliferative diabetic retinopathy (PDR) in 2019 was outlined by Sobha Sivaprasad, UK, in presentations during the Diabetic Retina scientific session September 6 2019, at the 19th European Society...2018 update on intravitreal injections
1 December 2018
| Sofia Rokerya
|
Retina / Uvea / Vitreous
|
Intravitreal injections, Treatment of retinal diseases, Vitreoretinal diseases
In this review article the authors have highlighted the standardised and structured approach to intravitreal injections (IVI) by examining the recent evidence-based literature. IVI is the most commonly performed procedure worldwide with low potential risk of endophthalmitis. IOP spikes are...
The focus group
1 June 2015
| Gwyn Samuel Williams
|
AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
I love conferences. Euretina I love above all others, and when it came to London in 2014 I was determined to attend. A few weeks before the conference was scheduled to begin a well-known pharmaceutical company sent me an email...
Neovascular AMD: fresh recommendations underline standards of best practice
1 December 2013
| Rod McNeil
The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...
Keep calm and cut the carbon – improving sustainability in ophthalmology
As I dump my tenth pair of gloves into a non-recyclable clinical waste bin; dispose of another handful of plastic minims; or print another wad of single-sided discharge paperwork after a cataract surgery, the inconvenient truth of how these seemingly...What’s new in wet AMD papers?
1 December 2016
| Rod McNeil
|
Retina / Uvea / Vitreous
Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...
In bed with Adnan Tufail
4 August 2021
| Gwyn Samuel Williams
|
AMD, Cataract and Refractive, Cornea / External Eye Disease, COVID-19, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
I used to like conferences. In fact, I loved them. When Euretina was in Paris in 2019 I met up with friends and colleagues, went out to bars and restaurants and took some time to see the Arc de Triomphe...
Update on emerging therapies for age-related macular degeneration
4 December 2023
| Rod McNeil
|
AMD
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...